"Situé au nord-est de l’agglomération chalonnaise, l’Hôpital privé Sainte-Marie dispose de 241 lits et places. Il réunit une centaine de praticiens et dénombre 340 salariés. Il est rattaché au Groupe Ramsay Santé depuis 1991. Il assure une prise en charge pluridisciplinaire dans les domaines de la chirurgie, médecine, chimiothérapie et dialyse. Il est labellisé Institut de cancérologie du groupe Ramsay Santé en juillet 2018."

During the past decade, Hôpital Privé Sainte Marie conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Privé Sainte Marie" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 5 trials, followed by "UNICANCER" with 3 trials sponsored, "ARCAGY/ GINECO GROUP" with 1 trials sponsored, "Centre Hospitalier Universitaire de Besancon" with 1 trials sponsored and "FX Solutions" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Privé Sainte Marie" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator, "Societe Francaise de Radiotherapie Oncologique" with 1 trials as a collaborator and "UNICANCER" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Privé Sainte Marie" are "Colorectal Cancer" (2 trials), "Aneurysm" (1 trials), "Aortic Aneurysm" (1 trials), "Aortic Aneurysm, Abdominal" (1 trials) and "Aortic Diseases" (1 trials). Many other conditions were trialed in "Hôpital Privé Sainte Marie" in a lesser frequency.

Most popular intervention types in "Hôpital Privé Sainte Marie" are "Drug" (9 trials), "Other" (5 trials), "Device" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "conventional surgery" (2 trials), "fluorouracil" (2 trials), "neoadjuvant therapy" (2 trials), "radiation therapy" (2 trials) and "5 FU bolus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Privé Sainte Marie" are 11 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hôpital Privé Sainte Marie". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hôpital Privé Sainte Marie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Privé Sainte Marie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".